A number of Indian medical experts on Monday supported calls from an eminent British Indian cardiologist for a full safety review into the use of Oxford/AstraZeneca's Covid-19 vaccine, administered in India as Covishield, over feared serious side effects such as heart attack and stroke.
Balakrishnan, a full professor in the economics department who joined the private university in 2015, on Saturday wrote to Ashoka University Chancellor Rudrangshu Mukherjee and board of trustees chairperson Pramath Raj Sinha explaining his reasons for his resignation.
The Oxford graduate is the daughter of medical professionals from Tamil Nadu.
'The FY2023 inflation outcome is likely to exceed the RBI's current forecast by a wide margin.'
Following up first doses of the AstraZeneca or Pfizer vaccines with second doses of the Moderna or Novavax jabs generates robust immune response against COVID-19, according to a study published in The Lancet journal.
'Later, I asked Hrithik how he could have remained so calm in the circumstances. He told me simply, "What could have happened? At the most, they would have killed me".'
If the vaccine is recommended for use as a booster against Omicron, it may significantly boost the demand for Covishield in India.
Two doses of Pfizer and AstraZeneca COVID-19 vaccines generate lower levels of antibodies against the Omicron variant of coronavirus, according to a study which suggests that those previously infected or vaccinated may be at an increased risk of infection.
Here are some facts about Rishi Sunak and his India connections.
It's not every day that an undergraduate from India wins a scholarship to study at one of the prestigious universities in the world.
'Assassinating the leaders of an organisation, destroying their homes, buildings and institutions are not 'wiping out' an organisation.' 'Genociding the Lebanese or the Palestinians is something that Israel cannot technically do, let alone morally afford.'
"I realise that a lot of Indians who have taken Covishield are facing issues with travel to the EU, I assure everyone, I have taken this up at the highest levels and hope to resolve this matter soon, both with regulators and at a diplomatic level with countries," Poonawalla said in a tweet.
British Indian think tank 1928 Institute organised a special roundtable entitled 'India and the Indo-Pacific' bringing together the High Commissioners of India, Bangladesh, Australia, Canada, Nepal, among others, ahead of the reception in the River Room of the House of Lords on Monday evening.
Major General S C N Jatar, who passed into the ages on Monday night, thwarted anti-national forces at the peak of the Assam agitation. Colonel Anil A Athale (retd) salutes this officer and gentleman.
Economist Abhijit Sen, a former Planning Commission member and one of the country's foremost experts on rural economy, died on Monday night. He was 72.
SII has signed an agreement to manufacture the potential vaccine developed by Jenner Institute of Oxford University in collaboration with British-Swedish pharma company AstraZeneca.
The researchers analysed 2580,021 test results from nose and throat swabs taken from 384,543 participants aged 18 years or older between December 1, 2020 and May 16, 2021.
Akshata Murty, the wife of Britain's Prime Minister Rishi Sunak, stands to earn Rs 68.17 crore in dividend income from her shareholding in India's second-largest IT firm Infosys. Murty, daughter of Infosys co-founder Narayana Murthy, held 3.89 crore shares of Infosys at the end of December, according to company filings with the stock exchanges. Infosys declared a final dividend of Rs 17.50 per share for FY23 (April 2022 to March 2023).
Amid concerns over dangerous side-effects of the Oxford's COVID-19 vaccine, India is evaluating all serious adverse events post-vaccination to determine the causality aspects of Covishield and Covaxin, an expert associated with the process said on Saturday.
SII would be scaling up its AstraZeneca-Oxford vaccine manufacturing capacity to 200 million doses a month from 100 million a month now, reports Sohini Das.
Khan was convicted in the Toshakhana case which was filed last year on the complaint of the Election Commission of Pakistan (ECP) which had earlier disqualified him in the same case.
The expert committee sought more information from Serum Institute regarding the Oxford-AstraZeneca vaccine.
Rahi Chadda was one of the few desi models to attend Milan fashion Week 2022.
Pratishtha Deveshwar learnt to reframe her anguish into an opportunity for action. She felt that God had given her an opportunity to make an impact on the wider world.
Rocky Aur Rani Kii Prem Kahani packs in abundant entertainment and hat tips to the KJo brand, observes Sukanya Verma.
Covaxin has been indigenously developed by Bharat Biotech in collaboration with the Indian Council of Medical Research.
The government on Friday appointed Suman K Bery as the vice chairman of Niti Aayog, following the sudden resignation of Rajiv Kumar.
According reports, the pilot is reported to have stolen the small aircraft.
There is confusion over the United Kingdom government's vaccine recognition process for Indian travellers as even though Oxford/AstraZeneca Covishield, the India-manufactured Oxford/AstraZeneca COVID-19 vaccine, is on an updated international travel advisory, India is not yet on a list of 17 approved countries.
'Our civil society here is vibrant, and courageous, although it is beaten up and beaten down, repeatedly.'
While it is not clear whether the volunteer had received the vaccine or a placebo shot during the trial, Anvisa has refused to reveal any more information citing reasons of medical privacy, CNN reported.
An Oxford, and Stanford University alumnae, Sunak is famously married to Akshata Murty, the daughter of billionaire Narayana Murthy.
Global forecasting firm Oxford Economics on Monday revised downwards its India GDP growth forecast for 2021 to 10.2 per cent from 11.8 per cent previously, citing the country's escalating health burden, faltering vaccination rate and lack of a convincing government strategy to contain the pandemic. Oxford Economics also said that notwithstanding the likelihood of further mobility restrictions, it expects India's targeted lockdown approach, less stringent restrictions, and resilient consumer and business behaviour to mitigate the economic impact of the second wave.
'Once DCGI will give us the permission to restart the trials in India, we will resume the trials,' Serum Institute of India (SII) said in a statement.
The vaccine, ChAdOx1 nCoV-19 and also known as AZD1222, is considered among the most advanced in the worldwide hunt for a viable vaccine against the novel coronavirus.
Currently, phase 2 and 3 clinical trials of the Oxford vaccine candidate is going on in the United Kingdom, phase 3 clinical trial in Brazil and phase 1 and 2 clinical trials in South Africa.
The move comes even as India's drug regulator has extended Covishield's shelf life from six to nine months from its manufacturing date.
The UK government is under increasing pressure on Monday to review its COVID-19 vaccine protocol in place for travellers from India, after its updated rules effective from next month failed to recognise Indian vaccines under an expanded list of countries.
His visit to India followed a few cancelled plans since he took office in July 2019 due to the coronavirus pandemic crisis, with the two leaders holding several virtual talks and eventually meeting in person on the sidelines of the COP26 climate summit in Glasgow last November.